Live News

Journals & Papers, Articles
Haematology 柳叶刀4
[Comment] Patient-reported outcomes: important data in early trials of novel therapies
Multiple myeloma is an incurable disease that has nonetheless been the focus of substantial treatment advances over ...
[In Focus] Abortion access and the US medical workforce: a looming crisis for haematology
The June 24, 2022 Dobbs versus Jackson decision by the US Supreme Court has many grave implications; among them is t...
[Comment] Blinatumomab plus hyper-CVAD: the prelude to a new era in acute lymphocytic leukaemia
Blinatumomab, a CD19/CD3 bispecific T-cell engager active as monotherapy in relapsed or refractory B-cell acute lymp...
[Comment] Lenalidomide and risk of second primary malignancy—is disease context key?
Based on the current data, lenalidomide-induced SPM seem to occur exclusively in patients with multiple myeloma. Thus, len...
[Articles] Second primary malignancies in patients with haematological cancers treated with lenalidomide: a systematic review and meta-analysis
1.Modern multiple myeloma therapy: deep, sustained treatment response and good clinical outcomes.J Intern Med. 281: 365-38...
[Editorial] Increasing availability of oral therapy in haematology
With the availability of oral chemotherapy regimens as effective as those administered intravenously (eg, oral arsenic in ...
[Comment] Lower strength stockings: is less better?
Post-thrombotic syndrome is a common complication of deep vein thrombosis characterised by chronic tiredness of the ...